Why Pfizer sold its $3 billion stake in Haleon
Pfizer’s decision to offload $3.05 billion worth of shares in Haleon is a strategic move driven by shifting priorities in a ...
Pfizer going 'all in' on obesity drug development, CEO Bourla says
U.S. drugmaker Pfizer is going "all in" to develop its experimental obesity drug and has been recruiting more experts in that ...
GlobalData on MSN1d
Pfizer believes in the metaverse: will healthcare thaw the technology’s winter?
The metaverse hype is over, but developer Cassette Group has been working with Pfizer to realise its forgotten potential.
FiercePharma1d
Novo's semaglutide among 2nd batch of drugs selected for IRA price negotiations
The U.S. government has selected the second batch of drugs up for Medicare price negotiations under the Inflation Reduction ...
Pfizer Further Pares Haleon Stake With £2.5 Billion Sale
Pfizer Inc. sold about 700 million shares in Haleon Plc, further paring its stake in the maker of Sensodyne toothpaste.Most ...
GSK, Pfizer RSV shots must warn about rare paralysis risk
Barré for every million doses given.
usaherald3d
Pfizer Cuts Stake in Haleon PLC with $2.6 Billion Share Sale
Pfizer has reduced its stake in the British healthcare company Haleon PLC to 7.3% by selling £2.5 billion ($3 billion) worth ...
FiercePharma10d
RSV vaccines from Pfizer, GSK take another hit with new FDA warning mandate
The FDA will require GSK and Pfizer to include on the label of their respiratory syncytial virus (RSV) vaccines a warning ...
Pfizer (NYSE:PFE) Stock Price Down 0.8% on Analyst Downgrade
Pfizer Inc. (NYSE:PFE – Get Free Report)’s share price fell 0.8% during trading on Thursday after UBS Group lowered their price target on the stock from $31.00 to $29.00. UBS Group currently has a ...